Victory Capital Management Inc Morphic Holding, Inc. Transaction History

Victory Capital Management Inc

$98.4 Billion
Q1 2024

A detailed history of Victory Capital Management Inc transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 29,100 shares of MORF stock, worth $991,437. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,100

Previous 13,630 113.5%

Holding current value

$991,437

Previous $393,000 160.56%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$26.64 - $40.31 $412,120 - $623,595	15,470 Added 113.5%	29,100 $1.02 Million
Q4 2023 Feb 05, 2024	BUY	$19.95 - $31.0 $26,413 - $41,044	1,324 Added 10.76%	13,630 $393,000
Q3 2023 Nov 06, 2023	SELL	$21.33 - $59.42 $6.57 Million - $18.3 Million	-308,035 Reduced 96.16%	12,306 $281,000
Q2 2023 Jul 27, 2023	BUY	$34.33 - $62.11 $1.16 Million - $2.09 Million	33,699 Added 11.76%	320,341 $18.4 Million
Q1 2023 May 02, 2023	BUY	$26.01 - $48.69 $7.46 Million - $14 Million	286,642 New	286,642 $10.8 Million

Q1 2022 May 04, 2022	SELL	$36.25 - $52.02 $288,876 - $414,547	-7,969 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$43.27 - $65.72 $268,923 - $408,449	-6,215 Reduced 43.82%	7,969 $378,000
Q3 2021 Nov 02, 2021	BUY	$53.61 - $67.5 $286,331 - $360,517	5,341 Added 60.4%	14,184 $803,000
Q2 2021 Aug 03, 2021	BUY	$45.13 - $64.99 $399,084 - $574,706	8,843 New	8,843 $508,000
Q2 2020 Aug 07, 2020	SELL	$12.65 - $29.57 $20,037 - $46,838	-1,584 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$10.84 - $20.85 $2,731 - $5,254	-252 Reduced 13.73%	1,584 $23,000
Q4 2019 Feb 04, 2020	BUY	$13.02 - $19.5 $10,051 - $15,054	772 Added 72.56%	1,836 $37,000
Q3 2019 Nov 12, 2019	BUY	$17.46 - $29.05 $18,577 - $30,909	1,064 New	1,064 $19,000

Others Institutions Holding MORF

# of Institutions

142

Shares Held

37.9M

Call Options Held

13.5K

Put Options Held

190K

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $1.31B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Morphic Holding, Inc. Transaction History